All In Biotech

Drug Trial Radar · NCT05708677

A Long-Term Extension Study for Participants Previously Treated With EB-101 for the Treatment of RDEB

A Long-Term Extension Study for Participants Previously Treated With EB-101 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB)

Last checked: Nov 19, 2026Latest source record: Jul 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Enrolling by invitation

Status

Enrolling by invitation

Enrollment

22

Planned (sponsor's estimate)

Start

Feb 9, 2021

Primary completion

Feb 2036

Study completion Aug 2036

Sponsor

Lead sponsor
Abeona Therapeutics, IncIndustry
Sponsor type
Industry
First posted
Feb 1, 2023

More drug trials from this sponsor

Design

Study type
Observational
FDA-regulated drug
Yes
Who can join
All sexes, from 6 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A Long-Term Extension Study for Participants Previously Treated with EB-101 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB)

Conditions

  • RDEB

Interventions

  • EB-101Biological

    This is non-interventional and follows patients treated with EB-101

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Wound ClosureTime frame: 5 years
  2. Pain Severity Scale (Wong-Baker FACES)Time frame: 5 years
  3. Itch Severity ScaleTime frame: 5 years
  4. Zarit Burden Interview ScaleTime frame: 5 years
  5. Quality of Life in Epidermolysis BullosaTime frame: 5 years
  6. Caregiver Global Impression of Change for Pain ScaleTime frame: 5 years
  7. Wound Infection and Adverse EventsTime frame: 5 years
  8. The number of treatment-emergent adverse events.Time frame: 5 years
  9. Serious Adverse EventsTime frame: 5 years
  10. Incidence of squamous cell carcinoma.Time frame: 5 years
  11. Replication-competent retrovirus (RCR) statusTime frame: 5 years

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Stanford University

    Redwood City, California

  • University of Massachusetts Medical School

    Worcester, Massachusetts

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.